Our results indicate that in the controversy over the pro-tumor effects of γδ T cells, IL-17 secreting γδ T cells are likely absent in human tumors and would not exert pro-tumor effects in human CRC as has been previously reported. This evidence concerns the gene IL17A and neoplasm.